Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Clinical trial NCT02562755 · COMPLETED
Trial details
- NCT number
- NCT02562755
- Sponsor
- SillaJen, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2020-07-01
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.